NCT00004024View on ClinicalTrials.gov

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 1997

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

autologous tumor cell vaccine

BIOLOGICAL

muromonab-CD3

BIOLOGICAL

sargramostim

BIOLOGICAL

therapeutic autologous lymphocytes

PROCEDURE

surgical procedure

RADIATION

radiation therapy

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00004024 - Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma | Biotech Hunter | Biotech Hunter